Historically, the Late-Breaking Clinical Trials Session has been one of the most highly anticipated sessions at the Annual Scientific Sessions. Select authors presented groundbreaking work, and the September issue of HeartRhythm Journal will feature abstracts.
The Heart Rhythm Society recognizes that due to the scheduling requirements, some exciting and rapidly evolving research could not be completed in time for the abstract submission deadline. In an effort to highlight timely and novel work, the Scientific Sessions Program Committee developed a peer-reviewed session of late-breaking trials that allows for later submission.
Late-Breaking Clinical Trials
Thursday, May 15, 10:30 a.m.– noon
Moscone Convention Center, Room 104
Chair:
Leslie A. Saxon, MD, FHRS, USC Keck School of Medicine, Los Angeles, CA
- Effects of Dronedarone on Cardiovascular Outcomes in High-Risk Patients with Atrial Fibrillation or Atrial Flutter — Results of the ATHENA Trial
Stefan H. Hohnloser, MD, FHRS, J. W. Goethe University, Frankfurt, Germany
More on the ATHENA Trial » - A Randomized Comparison of Targeted Versus Usual Left Ventricular Lead Placement. The INCREMENTAL Study
Derek V. Exner, MD, MPH, Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada - AntiArrhythmics After Ablation of Atrial Fibrillation (5A Study)
Jean-Francois Roux, MD, Hospital of the University of Pennsylvania, Philadelphia, PA
More on the 5A Study » - Biventricular vs Right Ventricular Antitachycardia Pacing in the Termination of Ventricular Tachyarrhythmia in Patients Receiving Cardiac Resynchronization Therapy: The ADVANCE CRT-D Trial
Maurizio Gasparini, MD, Istituto Clinico Humanitas, Milan, Italy - Effect of Cardiac Resynchronization Therapy on Incidence of Spontaneous Ventricular Arrhythmias in Mild Heart Failure: Results from the REVERSE Trial
Michael R. Gold, MD, PhD, Medical University of South Carolina, Charleston, SC - Pacemaker Remote Follow-up Evaluation and Review: Results of the PREFER Trial
Bruce L. Wilkoff, MD, The Cleveland Clinic Foundation, Cleveland, OH
More on the PREFER Trial »
